Detailed answers about BIOTECH INNOVATION AND FUTURE HEALTH LIMITED, including incorporation, status, business activity, and accounts information.
When was BIOTECH INNOVATION AND FUTURE HEALTH LIMITED founded?
BIOTECH INNOVATION AND FUTURE HEALTH LIMITED was officially incorporated on 16 August 1996 and is registered under company number 03238421. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BIOTECH INNOVATION AND FUTURE HEALTH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BIOTECH INNOVATION AND FUTURE HEALTH LIMITED?
BIOTECH INNOVATION AND FUTURE HEALTH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BIOTECH INNOVATION AND FUTURE HEALTH LIMITED do?
BIOTECH INNOVATION AND FUTURE HEALTH LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is BIOTECH INNOVATION AND FUTURE HEALTH LIMITED's registered address?
The registered office address of BIOTECH INNOVATION AND FUTURE HEALTH LIMITED is REGENT HOUSE 316 BEULAH HILL, UPPER NORWOOD, LONDON, SE19 3HF. This is the official address filed with Companies House for legal and statutory correspondence.
Is BIOTECH INNOVATION AND FUTURE HEALTH LIMITED financially stable?
The most recent accounts for BIOTECH INNOVATION AND FUTURE HEALTH LIMITED were made up to 30 June 2024, filed as MICRO ENTITY. Next accounts are due by 31 March 2026.